PCMP-H31 Antibody

Overview of PCMP-H31 Antibody

PCMP-H31 Antibody (Product Code: CSB-PA887807XA01DOA) is a monoclonal antibody developed against the Arabidopsis thaliana (Mouse-ear cress) protein PCMP-H31. It is commercially available in 2 ml or 0.1 ml volumes and is primarily used in research applications such as immunohistochemistry (IHC) and Western blot (WB) . The antibody targets the protein encoded by the PCMP-H31 gene, which is associated with plant-specific transcriptional regulation, though its exact biological role remains under investigation .

Antibody Structure

PCMP-H31 Antibody follows the canonical immunoglobulin structure, comprising two heavy chains (HCs) and two light chains (LCs) arranged in a Y-shape . Key features include:

• Fab Regions: Contain variable domains (VH and VL) responsible for antigen binding. The complementarity-determining regions (CDRs), particularly CDR-H3, confer specificity to the PCMP-H31 protein .

• Fc Region: Mediates effector functions such as interactions with immune cells .

Target Protein: PCMP-H31

The antibody recognizes PCMP-H31, a plant-specific protein with a UniProt accession number Q9FLX6. While its precise function is not fully characterized, PCMP-H31 is hypothesized to play a role in transcriptional regulation or stress responses in Arabidopsis thaliana .

Comparative Analysis of Epitope Mapping Techniques

While PCMP-H31’s epitope has not been explicitly mapped, advanced methodologies used for other monoclonal antibodies provide insights into potential strategies:

• Peptide Arrays: Identify linear epitopes via overlapping peptide libraries .

• Hydrogen-Deuterium Exchange (HDX): Detects conformational epitopes by measuring solvent protection upon antibody binding .

• X-ray Crystallography: Resolves atomic-level interactions between antibodies and antigens .

For PCMP-H31, epitope characterization would likely involve peptide arrays or HDX due to its plant-specific context .

Limitations and Future Directions

Current data on PCMP-H31 Antibody is limited to vendor specifications (Cusabio) . Further research should:

1. Validate its specificity via knockout/knockdown models.

2. Characterize its epitope using structural biology techniques .

3. Explore cross-species reactivity for broader applicability.